Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 13 Show results per page	View Search Criteria \| Help With Results

Last Modified: 9/11/2007


1.		Phase II Chemotherapy with DHAC for Advanced Adult non-Small Cell Carcinoma of the Bronchus

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				CHNMC-IRB-4205 NCI-T84-0414D, T84-0414


2.		Phase II Chemotherapy with DHAC in Patients with non-Small Cell or Small Cell Bronchogenic Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				15 and over				NCI				MDA-DM-8466 NCI-T84-0494C, T84-0494

Last Modified: 10/1/1988


3.		Phase II Chemotherapy with DHAC in Patients with Metastatic Adenocarcinoma of the Colon (Summary Last Modified 10/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				over 18				NCI				OSU-84HO272 OSU-8507, NCI-T85-0008D, T85-0008


4.		Phase II Master Protocol for the Study of New Agents in the Treatment of Metastatic Adenocarcinoma of the Breast --- DHAC

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				ICC-86B1 NCI-T86-0076D, T86-0076

Last Modified: 5/1/1989


5.		Phase II Study of Dihydro-5-azacytidine in Patients with Malignant Mesothelioma (Summary Last Modified 05/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				15 to 80				NCI				MDA-DM-8654 NCI-T86-0154C, T86-0154

Last Modified: 5/1/1988


6.		Phase II Master Protocol for the Study of New Agents in Patients with Ovarian Carcinoma of Coelomic Epithelial Origin --- DHAC (Summary Last Modified 05/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 to 75				NCI				ICC-86G1 NCI-T86-0246D, T86-0246

Last Modified: 12/1/1991


7.		Phase II Study of Dihydro-5-azacytidine in Patients with Malignant Mesothelioma (Summary Last Modified 12/91)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				any age				NCI				SWOG-8842

Last Modified: 11/1/1991


8.		Phase II Chemotherapy with Dihydro-5-azacytidine in Patients with Advanced Malignant Melanoma (Summary Last Modified 11/91)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				MAYO-877007 NCI-T88-0024D, T88-0024

Last Modified: 7/5/2006


9.		Phase II Master Protocol for Chemotherapy in Patients with Malignant Mesothelioma --- Dihydro-5-Azacytidine

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				over 15				NCI				CLB-8833 CALGB-8833

Last Modified: 9/11/2007


10.		Phase II Master Protocol for Chemotherapy in Patients with Malignant Mesothelioma --- DHAC plus CDDP

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				over 15				NCI				CLB-9031 CALGB-9031

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute